Trials / Completed
CompletedNCT06024590
Outcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
Outcomes of Chlorhexidine Gluconate Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Northern Illinois Foot and Ankle Specialists · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Irrisept™ irrigation containing Chlorhexidine Gluconate (CHG) 0.05% in sterile water, is an irrigation method that may help reduce bacterial load considerably more than traditional saline irrigation.
Detailed description
The purpose of this clinical evaluation is to collect patient outcome data on Irrisept™ irrigation. This is a jet irrigation of 0.05% Chlorhexidine Gluconate (CHG) in sterile water delivered under pressure by manual compression of the bottle by the user. This treatment allows for management of bioburden in a wound through broad spectrum antimicrobial activity by the CHG as well as removal of debris from the wound bed. In this trial, participants with partial and full thickness diabetic foot ulcers (DFUs) - 'full skin thickness and extending through the subcutaneous or fat layers or to deeper structures such as tendon and fascia will receive standard of care treatment with indicated off-loading device (SOC) for their condition in addition to wound bed irrigation with Irrisept™ or saline Irrigation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Irrisept | Standard of care wound treatment with 150 mL of IrriseptTM irrigation of the wound at each follow up visit. |
| DEVICE | Saline | Standard of care wound treatment with 150 mL ration of Normal saline irrigation of the wound at each follow up visit |
Timeline
- Start date
- 2023-10-03
- Primary completion
- 2025-05-22
- Completion
- 2025-05-22
- First posted
- 2023-09-06
- Last updated
- 2025-07-28
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06024590. Inclusion in this directory is not an endorsement.